Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT.
Pagliuca S, Schmid C, Santoro N, Simonetta F, Battipaglia G, Guillaume T, Greco R, Onida F, Sánchez-Ortega I, Yakoub-Agha I, Kuball J, Hazenberg MD, Ruggeri A; Practice Harmonization and Guidelines Committee and the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia.
Harada K, Mizuno S, Yano S, Takami A, Ishii H, Ikegame K, Najima Y, Kako S, Ashida T, Shiratori S, Ota S, Onizuka M, Fukushima K, Fukuda T, Ichinohe T, Atsuta Y, Yanada M.
Ann Hematol. 2022 Mar;101(3):643-653. doi: 10.1007/s00277-021-04731-5. Epub 2022 Jan 6.
PMID:34988692
Donor-derived regulatory dendritic cell infusion modulates effector CD8(+) T cell and NK cell responses after liver transplantation.
Tran LM, Macedo C, Zahorchak AF, Gu X, Elinoff B, Singhi AD, Isett B, Zeevi A, Sykes M, Breen K, Srivastava A, Ables EM, Landsittel D, Styn MA, Humar A, Lakkis FG, Metes DM, Thomson AW.
Sci Transl Med. 2023 Oct 11;15(717):eadf4287. doi: 10.1126/scitranslmed.adf4287. Epub 2023 Oct 11.